Id: OpioidCDSREC10OrderSign Url: Library - Recommendation #10 - Urine Drug Testing Version: 2022.1.0 Name: OpioidCDSREC10OrderSign Title: Library - Recommendation #10 - Urine Drug Testing Status: active Experimental: false Type: system: http://terminology.hl7.org/CodeSystem/library-type code: logic-library Date: 2026-04-27 16:35:01+0000 Publisher: CDC / Security Risk Solutions, Inc. (SRS) Copyright: Centers for Disease Control and Prevention (CDC) Related Artifacts: Dependencies http://fhir.org/guides/cqf/common/Library/FHIR-ModelInfo|4.0.1 FHIR Helpers version: 4.0.1 Library - OpioidCDS Common version: 2022.1.0 Library - OpioidCDS Common Configuration version: 2022.1.0 Library - OpioidCDS Routines version: 2022.1.0 OpioidCDSREC10Common version: 2022.1.0 Parameters: Name Type Min Max In/Out ContextPrescriptions MedicationRequest 0 * In Patient Patient 0 1 Out Subacute or Chronic Pain Opioid Analgesic with Ambulatory Misuse Potential Prescriptions MedicationRequest 0 * Out Patient Is Being Prescribed Opioid Analgesic with Ambulatory Misuse Potential boolean 0 1 Out Is Perform Drug Screen Recommendation Applicable? boolean 0 1 Out Applicable Because of Unexpected Results boolean 0 1 Out Detail string 0 1 Out Get Subject string 0 1 Out Get Lab Category CodeableConcept 0 1 Out Data Requirements: Type Profile MS Code Filter Patient http://hl7.org/fhir/StructureDefinition/Patient Content: text/cql library OpioidCDSREC10OrderSign version '2022.1.0' using FHIR version '4.0.1' include FHIRHelpers version '4.0.1' called FHIRHelpers include OpioidCDSCommon version '2022.1.0' called Common include OpioidCDSCommonConfig version '2022.1.0' called Config include OpioidCDSRoutines version '2022.1.0' called Routines include OpioidCDSREC10Common version '2022.1.0' called Rec10Common /* ** Recommendation #10 ** When prescribing opioids for subacute or chronic pain, clinicians should consider the benefits ** and risks of toxicology testing to assess for prescribed medications as well as other prescribed ** and nonprescribed controlled substances (recommendation category: B; evidence type: 4). ** ** When ** Provider is prescribing an opioid analgesic with ambulatory misuse potential in the outpatient setting: ** Prescription is for treating subacute and/or chronic pain. ** CDC 2022 guideline general inclusion criteria met for this patient: ** Patient is 18 or over ** Patient does not have evidence of sickle cell disease ** Patient does not have findings indicating limited life expectancy ** Patient does not have orders for therapies indicating end of life care ** Patient is not undergoing active cancer treatment: ** Patient has had at least 2 office visits within the past 12 months with an oncology specialist present, or ** Patient has had at least 2 office visits within the past 12 months with a CDC malignant cancer condition diagnosis ** Patient does not have conditions likely terminal for opioid prescribing present ** Nonopioid drug urine screening has not been performed in last 12 months or ** Opioid drug urine screening has not been performed in last 12 months ** Then ** Consider the benefits and risks of conducting a urine toxicology screen: ** Document - Order toxicology screen ** Document risks outweigh benefits ** Snooze - N/A see comment, snooze 3 months ** When ** Provider is prescribing an opioid analgesic with ambulatory misuse potential in the outpatient setting: ** Prescription is for treating subacute and/or chronic pain. ** CDC 2022 guideline general inclusion criteria met for this patient: ** Patient is 18 or over ** Patient does not have evidence of sickle cell disease ** Patient does not have findings indicating limited life expectancy ** Patient does not have orders for therapies indicating end of life care ** Patient is not undergoing active cancer treatment: ** Patient has had at least 2 office visits within the past 12 months with an oncology specialist present, or ** Patient has had at least 2 office visits within the past 12 months with a CDC malignant cancer condition diagnosis ** Patient does not have conditions likely terminal for opioid prescribing present ** Nonopioid drug urine screening has been performed in last 12 months and ** Opioid drug urine screening has been performed in last 12 months and ** Positive result for synthetic opioid in the past year and not currently prescribed synthetic opioid or ** Positive result for phencyclidine(PCP) in the past year or ** Positive result for fentanyl in the past year and not currently prescribed fentanyl or ** Positive result for cocaine in the past year or ** Positive result for amphetamine in the past year and not currently prescribed amphetamine or ** Positive result for tetrahydrocannabinol (THC) in the past year and not currently prescribed tetrahydrocannabinol (THC) or ** Positive result for opiate in the past year and not currently prescribed natural opiate or ** Positive result for alcohol in the past year or ** Positive result for methadone in the past year and not currently prescribed methadone ** Then ** Patient may have unexpected toxicology test results: ** Document - Will repeat urine drug screening more frequently ** Document - Will assess patient for substance use disorder ** Snooze - Patient's test results were expected, snooze for 3 months ** Snooze - N/A snooze for 3 months ** */ // META: Plan Definition: http://fhir.org/guides/cdc/opioid-cds-r4/PlanDefinition/opioid-cds-10-order-sign parameter ContextPrescriptions List<MedicationRequest> context Patient define "Subacute or Chronic Pain Opioid Analgesic with Ambulatory Misuse Potential Prescriptions": ( Common."Is Opioid Analgesic with Ambulatory Misuse Potential?"( ContextPrescriptions ) ) AmbulatoryOpioidPrescription where Routines."Is Subacute or Chronic Pain Prescription?"( AmbulatoryOpioidPrescription ) define "Patient Is Being Prescribed Opioid Analgesic with Ambulatory Misuse Potential": exists( "Subacute or Chronic Pain Opioid Analgesic with Ambulatory Misuse Potential Prescriptions" ) define "Is Perform Drug Screen Recommendation Applicable?": "Patient Is Being Prescribed Opioid Analgesic with Ambulatory Misuse Potential" and Rec10Common."Inclusion Criteria For UDS Recommendation" define "Applicable Because of Unexpected Results": "Patient Is Being Prescribed Opioid Analgesic with Ambulatory Misuse Potential" and Rec10Common."Inclusion Criteria For Unexpected Results" define "Detail": Rec10Common."Get HTML Details" define "Get Subject": 'Patient/' + Patient.id /* <category> <coding> <system value="urn:oid:1.2.840.114350.1.13.861.1.7.10.798268.30" /> <display value="Lab" /> </coding> <text value="Lab" /> </category> */ define "Get Lab Category": FHIR.CodeableConcept { coding: { FHIR.Coding { system: FHIR.uri { value: 'urn:oid:1.2.840.114350.1.13.861.1.7.10.798268.30'}, code: FHIR.code { value: '7' }, display: FHIR.string { value: 'Lab' } } } } Content: application/elm+xml Encoded data (30376 characters) Content: application/elm+json Encoded data (47380 characters)
Library - Recommendation #10 - Urine Drug Testing
CDC / Security Risk Solutions, Inc. (SRS)
Centers for Disease Control and Prevention (CDC)
Subacute or Chronic Pain Opioid Analgesic with Ambulatory Misuse Potential Prescriptions
Patient Is Being Prescribed Opioid Analgesic with Ambulatory Misuse Potential
Is Perform Drug Screen Recommendation Applicable?
Applicable Because of Unexpected Results